Annual report pursuant to Section 13 and 15(d)

Aytu Divestiture - Summary of Income Statement (Details)

v3.20.4
Aytu Divestiture - Summary of Income Statement (Details) - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Operating expenses:    
Change in value of Guarantee $ 1,755,000 $ 0
Pediatric Portfolio | Discontinued Operations, Disposed of by Sale    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Product revenue, net (871,221) 10,166,611
Operating expenses:    
Cost of product sales 0 4,288,234
General and administrative 0 137,911
Sales and marketing 0 8,521,190
Amortization expense 0 2,425,083
Impairment of intangible assets 0 1,449,121
Change in fair value of contingent consideration 0 247,042
Total operating expenses 0 17,068,581
Change in value of Guarantee 1,755,000 0
Interest expense, net 0 (793,860)
Total other income (expense) 1,755,000 (793,860)
Gain on sale of Pediatric Portfolio 0 7,964,924
Income from discontinued operations before tax 883,779 269,094
Income tax expense 0 70,888
Income from discontinued operations, net of tax $ 883,779 $ 198,206